Trending news
Analyze
Pricing
CRISPR Therapeutics

CRISPR Therapeutics

Work at CRISPR Therapeutics? Add yourself to this profile

CRISPR Therapeutics

Elsewhere

Alexa global traffic share

Latest funding Show all
IPO
$56,000,000
Venture capital (Series B)
$38,000,000
New Leaf Venture Partners, Franklin Templeton Investments, Wellington Capital Management, +1
Employees

Team size

10+
Locations
HQ
$56,000,000 IPO
Xconomy

CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals' Haul

$38,000,000 Venture capital (Series B)
FierceBiotech , businesswire

CRISPR Therapeutics adds $38M to Series B pot, but lags behind Parker

Funding Science Health
$64,000,000 Venture capital (Series B)
FierceBiotech

As patent battle brews, Celgene and GSK lead $64M raise for CRISPR Therapeutics

Xconomy

Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture